Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.

Yang, Jianzhou

Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. [electronic resource] - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases May 2011 - e336-41 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1878-3511

10.1016/j.ijid.2011.01.007 doi


Adult
Age Factors
Anti-Infective Agents--adverse effects
Chronic Disease
Cohort Studies
Confidence Intervals
Databases, Factual
Drug Prescriptions--statistics & numerical data
Female
Humans
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Logistic Models
Parity
Pregnancy
Pregnancy Complications, Infectious--drug therapy
Premature Birth--chemically induced
Retrospective Studies
Risk Factors
Saskatchewan--epidemiology
Socioeconomic Factors
Trimethoprim, Sulfamethoxazole Drug Combination--adverse effects
United States
United States Food and Drug Administration
Young Adult